Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) Equity Average (2023 - 2026)

BioAge Labs' Equity Average history spans 2 years, with the latest figure at $274.8 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 13.72% to $274.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $274.8 million, a 13.72% decrease, with the full-year FY2025 number at $297.6 million, up 297.5% from a year prior.
  • Equity Average hit $274.8 million in Q4 2025 for BioAge Labs, down from $286.1 million in the prior quarter.
  • Over the last five years, Equity Average for BIOA hit a ceiling of $318.4 million in Q4 2024 and a floor of -$191.3 million in Q2 2024.